Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Effect of the Covid-19 pandemic on drug-resistant tuberculosis treatment outcomes at a national referral hospital in Sierra Leone, 2017 to 2022

A retrospective cohort study

Bibliographic Data

ID19593078
AuthorsJosephine Amie Koroma (University of Sierra Leone), Mariama Mahmoud (University of Sierra Leone), Bailah Molleh (0000-0002-9735-8038, Sierra Leone Urban Research Centre), Stephen Sevalie (0000-0003-2267-253X, University of Sierra Leone), Adrienne K Chan (0000-0002-9187-9465, University of Toronto), Sharmistha Mishra (0000-0001-8492-5470, University of Toronto), Sulaiman Lakoh (0000-0002-7639-0004, University of Sierra Leone, corresponding author), Joseph Sam Kanu (0000-0003-0799-6907, University of Sierra Leone)
EditorsDione Benjumea-Bedoya
Year2026
Volume6
Issue3
Pagese0004472
Publication date2026-03-04
Open AccessYes
TypeARTICLE
VenuePLOS Global Public Health (JOURNAL)
Journal identifiersISSN: 2767-3375 • E-ISSN: 2767-3375
PublisherPublic Library of Science (PLoS) (PUBLISHER)
DOI10.1371/journal.pgph.0004472
PMID41779701
OpenAlexW7133555370
LanguageEN
References cited17

Sierra Leone is one of the 30 high TB burden countries in the world, with an incidence rate in 2023 of 273 per 100,000 population. Despite progress in case notification and treatment coverage, around 5,000 cases of TB in Sierra Leone are missing each year. The COVID-19 pandemic has further compounded these challenges. We highlight its effect on drug-resistant TB treatment outcomes. We conducted a retrospective cohort study of drug-resistant TB cases using national data from January 2017 to December 2022. Data was analyzed using STATA. Descriptive analysis summarized demographic, clinical characteristics and treatment outcomes. Logistic regression examined the association between time-period and outcomes, adjusting for age, gender, nutritional status, HIV status and regimen. Of 701 patients, 383 (54.6%) were registered pre-COVID-19, 228 (32.5%) during, and 92 (13.1%) post-COVID-19. Pre-treatment TB cases reduced from 359 (92.5%) in the pre-COVID-19 period to 80 (30.9%) in the COVID-19 period. New treatment cases increased from 29 (7.5%) to 159 (61.4%) during COVID-19. Treatment completion decreased from 74.7% pre-COVID-19 to 63.3% during and 68.5% post-COVID-19). Malnourished patients had higher odds of success (aOR: 1.482, 95% CI: 1.007-2.183), while those on short regimen had lower odds (aOR: 0.51, 95% CI: 0.321-0.810). We observed a decline in drug-resistant TB treatment success rate during COVID-19, which was primarily influenced by concurrent shifts in treatment protocols and underlying secular trends. The pandemic itself did not emerge as an independent determinant of poor treatment outcomes, highlighting the resilience of the TB care system. Nonetheless, the pandemic had significant indirect consequences, including worsening rates of malnutrition and HIV co-infection. These trends point to deeper systemic vulnerabilities, such as weak social protection mechanisms, increased food insecurity, and disruptions in HIV service delivery, all of which contributed to delay in diagnosis and compromised treatment adherence

Incidence (geometry) · Logistic regression · Odds · Odds ratio · Pandemic · Referral · Retrospective cohort study · Tuberculosis · Antibiotic Use and Resistance · Diverse Scientific Research Studies · Tuberculosis Research and Epidemiology

  • Impact of Covid-19 on the Utilization of HIV Testing and Linkage Services in Sierra Leone

    Open Access•Sulaiman Lakoh, Moses M Bangura et al.•AIDS and Behavior•2023

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae